Recovery from heart failure with circulatory assist: A working group of the national, heart, lung, and blood institute

被引:16
|
作者
Reinlib, L
Abraham, W
机构
[1] US Dept HHS, NHLBI, Div Heart & Vasc Dis, NIH, Bethesda, MD USA
[2] Ohio State Univ, Div Cardiol, Columbus, OH 43210 USA
关键词
heart failure; LVAD; circulatory assist; devices; mechanical circulatory support;
D O I
10.1016/S1071-9164(03)00592-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Over the past decade, mechanical circulatory support has been beneficial as a bridge to cardiac transplantation, and anecdotal evidence suggests that heart failure patients fitted with mechanical assist devices experience direct cardiac benefits. Moreover, recent trials on limited numbers and subpopulations of patients-notably the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH)-support earlier observations of improved cardiac function and point towards the use of assist devices as destination therapy. Methods and Results: To investigate this phenomenon, on August 2-3, 2001, the National Heart, Lung, and Blood Institute convened the working group, "Recovery from Heart Failure with Circulatory Assist" in Bethesda, Maryland. The team included cardiac surgeons, cardiologists, and experts in experimental research. The goal was to prioritize recommendations to guide future programs in: (1) elucidating the mechanisms leading to reverse remodeling associated with a left ventricular assist device (LVAD); (2) exploring advanced treatments, including novel pharmacologies, tissue engineering, and cell therapies, to optimize recovery with LVAD therapy; and (3) identifying target genes, proteins, and cellular pathways to focus on for production of novel therapies for myocardial recovery and cardiovascular disease. Conclusions: The working group also made research and clinical recommendations to eventually translate findings into improved therapeutic strategies and device design: (1) support collaborations among clinical and basic scientists with an emphasis on clinical/translational research that might eventually lead to clinical trials; (2) identify candidate patients most likely to benefit from LVAD as a destination therapy; (3) explore potential biomarkers indicating when patients could most successfully be weaned from devices; and (4) promote clinical and experimental study of mechanically assisted organs and the tissue derived from them.
引用
收藏
页码:459 / 463
页数:5
相关论文
共 50 条
  • [31] National Heart Lung and Blood Institute
    黄亚明
    中华内科杂志, 2010, (03)
  • [32] News from the National Heart, Lung, and Blood Institute
    Lenfant, C
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1999, 277 (03): : H855 - H855
  • [33] Thrombosis in Cancer: Research Priorities Identified by a National Cancer Institute/National Heart, Lung, and Blood Institute Strategic Working Group
    Key, Nigel S.
    Khorana, Alok A.
    Mackman, Nigel
    McCarty, Owen J. T.
    White, Gilbert C.
    Francis, Charles W.
    McCrae, Keith R.
    Palumbo, Joseph S.
    Raskob, Gary E.
    Chan, Andrew T.
    Sood, Anil K.
    CANCER RESEARCH, 2016, 76 (13) : 3671 - 3675
  • [34] Future research directions in acute lung injury - Summary of a National Heart, Lung, and Blood Institute working group
    Matthay, MA
    Zimmerman, GA
    Esmon, C
    Bhattacharya, J
    Coller, B
    Doerschuk, CM
    Floros, J
    Gimbrone, MA
    Hoffman, E
    Hubmayr, RD
    Leppert, M
    Matalon, S
    Munford, R
    Parsons, P
    Slutsky, AS
    Tracey, KJ
    Ward, P
    Gail, DB
    Harabin, AL
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (07) : 1027 - 1035
  • [35] Guidelines of the national heart, lung, and blood institute working group on blood drawing, processing, and storage for genetic studies
    Austin, MA
    Ordovas, JM
    Eckfeldt, JH
    Tracy, R
    Boerwinkle, E
    Lalouel, JM
    Printz, M
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1996, 144 (05) : 437 - 441
  • [36] Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research
    Cohn, JN
    Bristow, MR
    Chien, KR
    Colucci, WS
    Frazier, H
    Leinwand, LA
    Lorell, BH
    Moss, AJ
    Sonnenblick, EH
    Walsh, RA
    Mockrin, SC
    Reinlib, L
    CIRCULATION, 1997, 95 (04) : 766 - 770
  • [37] National Heart, Lung, and Blood Institute Transitions
    Nabel, Elizabeth G.
    CIRCULATION, 2009, 119 (10) : 1453 - 1455
  • [38] FUNDING FROM THE NATIONAL HEART, LUNG, AND BLOOD INSTITUTE.
    Shurin, S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [39] REPORT FROM THE NATIONAL-HEART-LUNG-AND-BLOOD-INSTITUTE
    HORAN, MJ
    HYPERTENSION, 1985, 7 (03) : I161 - I161
  • [40] Knowledge gaps in heart and lung donation after the circulatory determination of death: Report of a workshop of the National Heart, Lung, and Blood Institute
    Bernat, James L.
    Khush, Kiran K.
    Shemie, Sam D.
    Hartwig, Matthew G.
    Reese, Peter P.
    Ave, Anne Dalle
    Parent, Brendan
    Glazier, Alexandra K.
    Capron, Alexander M.
    Craig, Matt
    Gofton, Teneille
    Gordon, Elisa J.
    Healey, Andrew
    Homan, Mary E.
    Ladin, Keren
    Messer, Simon
    Murphy, Nick
    Nakagawa, Thomas A.
    Parker, William F.
    Pentz, Rebecca D.
    Rodriguez-Arias, David
    Schwartz, Bryanna
    Sulmasy, Daniel P.
    Truog, Robert D.
    Wall, Anji E.
    Wall, Stephen P.
    Wolpe, Paul R.
    Fenton, Kathleen N.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (06): : 1021 - 1029